Saturday Cinema with Le Fly: The Big Lebowski

This is my favorite comedy of all time. For some reason, it’s always on during Thanksgiving, so I am reminded of it this time of year.

It’s a story about a white russian drinking stoner on a mission to find a woman, teamed up with a violent Vietnman war vet and some other guy, whose journey borders on the obscene with lots of laughs along the way. If this movie doesn’t make you laugh at least 10 times, you’re an idiot…man.

It was a fine week. I have no complaints, other than the fact that two of my 5 top positions sucked wind. SHAK is acting like they’re purposely putting razor blades in their burgers. I get the fact that short sellers hate SHAK. Miserable bastards. But drilling it down like this is bound to boom-a-rang your face off. Next thing you know, kangaroos are boxing your teeth out from your mouth because you decided to hold SHAK one more day, short.

“The Fly” is cruising into National Festival with a 16% return for the year.

VRX is starting to get some day light. Look for Bill Ackman to exact revenge on you motherfuckers next week. I am long PAH, with Bill, praying for his victory.

My CNC position got GRAPED yesterday due to UNH. So they came out after the bell last night and said “yo, dawg, we ain’t UNH. Our bidness is straight booming. We’re selling cocaine out from the cellas. We’re really doing it, live wire, real talk.”

Funny thing about Live-Wire. That was the nick-name of my neighborhood bully. He’d walk around with box cutters, for the purposes of cutting people’s faces for their beepers. He’d like to say “LIVE WIRE THE GREATEST”,  just before slashing your face with his dirty razor. I grew up amongst savage animals, who deserved dying young. Trust me.

It looks like YELP bagholders are expecting a bid this weekend. I am holding a bag or two.

Finally, I added to my fucked FCX position today.

BTW: Exodus fucking nailed it again.

Our 12 mo algos are now running, efficiently, at a 90% win rate.

Out.

This stock is McDonald’s fucked. The brand is on the verge of undergoing a crisis. This will get significant airplay.

Via CDC website:

3 additional states have reported people infected with the outbreak strain of Shiga toxin-producing Escherichia coli O26 (STEC O26) since the last update.
45 people infected with the outbreak strain of STEC O26 have now been reported from a total of 6 states: California (2), Minnesota (2), New York (1), Ohio (1), Oregon (13), and Washington (26).
The epidemiologic evidence available at this time suggests that a common meal item or ingredient served at Chipotle Mexican Grill restaurants in several states is a likely source of this outbreak.
The investigation is still ongoing to determine what specific food is linked to illness.
CDC will advise the public if specific steps are identified that consumers can take to protect themselves.

 

CDC, the U.S. Food and Drug Administration, and public health officials in several states are investigating an outbreak of Shiga toxin-producing Escherichia coli O26 (STEC O26) infections.
As of November 19, 2015, 45 people infected with the outbreak strain of STEC O26 have been reported from 6 states.
16 ill people have been hospitalized. There have been no reports of hemolytic uremic syndrome and no deaths.
The epidemiologic evidence available at this time suggests that a common meal item or ingredient served at Chipotle Mexican Grill restaurants in several states is a likely source of this outbreak.
43 (96%) of 45 ill people interviewed reported eating at a Chipotle Mexican Grill restaurant in the week before their illness started.
The investigation has not identified what specific food is linked to illness.
Chipotle Mexican Grill is assisting public health officials with understanding the distribution of food items served at locations where ill people ate and this work is ongoing.
Investigators are using whole genome sequencing, an advanced laboratory technique, to get more information about the DNA fingerprint of the STEC O26 bacteria causing illness.
To date, 10 STEC O26 isolates from ill people in Washington (9) and Minnesota (1) were found to be highly related genetically to one another.
CDC and state and local public health partners are continuing laboratory surveillance through PulseNet to identify additional ill persons and to interview them.
Consumers should contact a health care provider if they recently became ill with diarrheal symptoms after eating at a Chipotle Mexican Grill restaurant.
CDC will advise the public if specific steps are identified that consumers can take to protect themselves.

 

The stock is cratering, down 39 points or 6%.

Hypothetically, the price of crude stays fucked for the next 5 years. If so, I suspect companies laden with lots of debt will find it increasingly difficult to meet their covenants. I am sure you ponder, clad in your fruit of the loom bikini styled underwears, over there in your housing tenements, who might suffer the pangs of a deflationary death, given the pin action in crude.

Well, I have a list! Unlike Hitler, my list wasn’t made to hurt people, but instead help you avoid potential cataclysm.

(stock, debt burden, debt/eq level)

PBR $132 bill, 4.5x
SDRL $11.9 bill, 3.8x
PAGP $11.27 bill, 4.54x
LINE $10 bill, 13.4x (done)
CRC $6.4 bill, 4.12x
TRGP $6 bill, 2.57x
EPE $4.93 bill, 3.6x
UPL $3.41 bill, 5x

And for stocks that are almost assuredly heading for $00.00, barring a miracle.

PGN $2.61 bill, 144x
SFY $1.18 bill, 66x
ATLS $1.52 bill, 33x
PVA $1.19 bill, 32x
EXXI $4 bill, 27x
SSE $1.59 bill, 24x
NADL $2.67 bill, 17x
ORIG $4.83 bill, 15x
PACD $2.95 bill, 11x

data provided by Exodus

I am sure Nikolai Tesla is rolling over in his grave.

Actually, the recall isn’t that big a deal, but big enough to knock the stock from $222 to $217. How dare they!

Faulty seat-belts and shit, the shit that send your headlong into a wall of glass, crack your spine in half, sever your heads. No biggie.

“Tesla recently found a Model S in Europe with a front seat belt that was not properly connected to the outboard lap pretensioner,” the company said in an e-mail to customers Friday. “This vehicle was not involved in a crash and there were no injuries. However, in the event of a crash, a seat belt in this condition would not provide full protection. First and foremost, we care about your safety.”

I can’t wait for Tim “I’m Still Gay” Cook to come out with the iCar, straight bowling on these assclowns and their fucked up cars.

NOTE: Sorry for the deceptive front page pic. I could not help myself.

I am literally giving you an opportunity to jump above your social class, from the reader, to lauded and read blogger class. For some of you, this is an impossible task, due to a sundry of issues stemming from your inability to string english words together into decipher phrases and sentences. There is, however, opportunity to be had for the remaining well read few, those willing and able to bleed for iBC.

HERETOFORE: I am opening the floodgates of iBankCoin and permitting a select few of you to swim upstream, like a salmon, to the Peanut Gallery, a place destined for greatness.

Since opening the gallery, ideas and energy have been flowing from the bottom part of the site, formally known as its ass. I entreat you to email me at Flybroker @ gmail.com to submit a staked claim on one of the 5 blogs remaining in escrow. Be sure to tell me your Twitter handle; investigators are standing by.

For those who’ve already emailed me, I have seen your emails and have forwarded your staked claims to the claims department where our auditors are investigating your mental state and well being.

In case you’re wondering what I pay bloggers, dear lads, I pay in glory.

I came across this riveting article, albeit a little old, and was awestruck by it.

I recall hating on that Alfred Little guy–because he went after one of my Chinese positions. Although the process of trading ahead of market moving short reports is something I disdain, in hindsight, Mr. Little was correct.

China is a giant pile of heaping shit.

You want to invest in China? You like their ideals, their dog eating ways? Look at what they did to this guy for publishing bearish articles on SVM.

The punishments I jest about, that should be inflicted upon short sellers, aka bear shitters, are actually implemented in China.

Barbarous savages.

The stock is up over 60% 100% now on news that Shkreli, Anthion  management (David Moradi) and some guy with a last name that sounds like steak in spanish, are taking control of KBIO, claiming ownership of 70%.

I have my biases and definitely think KBIO will have to, one day, prove to the market that is deserves this absurd valuation. But, truth be told, this is a massive short squeeze, with the majority of the shares locked up by three guys–fucking with all of you.

I read commeents on Twitter and StockTwits, with all of these self proclaimed experts trying to pump their bias and have people follow them into hell; and I just shake my head.

Listen to me you little shits. Stop trying to ruin other people’s lives with your haphazard opinions and false intentions. You’re telling people to short KBIO, or buy KBIO, because of why? The kindness of your heart?

Please.

Sometimes a stock or a market is so fucked, you just need to sit back and watch. Slow the fuck down and stop embarassing yourselves.

It looks like the market wants to end the week higher. I’ve been doing some research in Exodus, trying to profile the winners of 2015, and as of late, and have some data to share.

I scanned for stocks up more than 20% year to date and here are the median metrics for the 792 stocks that was produced.

FPE: 18.95
YTD return: 37%
Qt earnings growth: 26%
Qt revenues growth: 9.6%
Market cap: 1.39 bill
P/S: 2.77
P/B: 3.58
Free cash flow: $39 mill
Debt/eq 0.10

I was surprised by these results, but not shocked. I expected a higher market cap number. Nevetheless, what this data tells us is the market wants free cash flow generating, in-line with market PEs, clean balance sheet, and fast earnings growing companies.

For members of Exodus, here is the screen.

For winners of 10% or more over the past month, here is the median profile data.

645 names produced

FPE: 18
1 mo return: 15%
Qt earnings growth: 14%
Qt revenue growth: 7%
Market cap: 1.1 billion
P/S: 2.33
P/B: 2.81
Free cash flow: $24.3 mill
Debt/Eq: 0.1

If you’re managing money for other people or for yourself, you want your portfolio to be in line with what the market is valuing. In other words, plug your portfolio into Exodus, providing you have a membership, and see where you diverge and how you might want to fix it.

I’ve already written a risk analyzer algorithm and will implement it in the next iteration of the software, along with robust portfolio functionality. Others try to do it; but I find their methods flawed. When assessing risk, there are a wide array of things that can go wrong; but this is basic stuff.

If you’re underperforming the market this year, I can guarantee you, your portfolio’s median metrics look nothing like this.

I love this guy like vampire hunters love vampires. It looks like Martin has 70% of KBIO shares and has even set up some financing. I’m guessing a reverse merger of Turing into KBIO is not likely to occur. Instead, Shkreli is going to try to turn around this dog of a horseshit stock into a player.

SOUTH SAN FRANCISCO, Calif., Nov. 19, 2015 /PRNewswire/ — KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that an investor group led by Martin Shkreli, the Founder and Chief Executive Officer of Turing Pharmaceuticals AG, has acquired 70% of its outstanding shares. KaloBios also announced the appointment of Martin Shkreli to the position of Chief Executive Officer and his election as Chairman of the Board. In his new role, Mr. Shkreli will work with the company’s senior management team to ensure the Company’s continued operations. KaloBios further announced that David Moradi, Tony Chase and Marek Biestek have been elected to the Board of Directors. In connection with these developments, the former directors have resigned, effective immediately.

KaloBios has received a commitment from Mr. Shkreli and other investors for an equity investment of at least $3.0 million. In addition, Mr. Shkreli and the group of investors have committed to a $10 million equity financing facility, subject to applicable shareholder approval.

Martin Shkreli, Chief Executive Officer, said, “We believe that the KaloBios’ lenzilumab is a very promising candidate for the treatment of various rare and orphan diseases. This monoclonal antibody neutralizes soluble granulocyte-macrophage colony stimulating factor (GM-CSF), a central actor in leukocyte differentiation, autoimmunity and inflammation. Lenzilumab has particular promise in Chronic Myelomonocytic Leukemia (CMML), a disease with no FDA-approved treatment options and a 3-year overall survival rate of 20%.”

An IND for a Phase I/II CMML monotherapy study of lenzilumab has been cleared by the Food and Drug Administration (NCT02546284). Preclinical studies have shown lenzilumab can be used to cause apoptosis in CMML cells by depriving them of GM-CSF. Lenzilumab may also have clinical utility in other rare autoimmune and inflammatory disorders. A 31-patient Phase I/II clinical trial of lenzilumab will begin enrollment at eight leading oncology clinical trial sites by year end 2015 with interim results possible as soon as the first half of 2016.

The company has approximately $5 million in cash and will endeavor to file its quarterly results on Form 10-Q as soon as possible. Mr. Shkreli will continue as Chief Executive Officer of Turing Pharmaceuticals AG and the two companies will operate independently.

Anyone want to guess where KBIO opens up tomorrow?